The development of cancer drugs is a lengthy and costly process that involves several stages:
Preclinical Research: Laboratory and animal studies to test the drug's safety and efficacy. Clinical Trials: Multi-phase trials involving human participants to assess the drug's safety, efficacy, and optimal dosing. Regulatory Approval: Submission of trial data to regulatory bodies like the FDA for approval. Post-Marketing Surveillance: Ongoing monitoring of the drug's performance and side effects in the general population.
